+ Pharmacokinetic parameters of<unk>  Bioavailability Tmax Cmax AUC Vd Plasma protein binding Metabolising enzymes t1/2 Excretion routes 58% 2.5-4.1 hr 27.8 ng/mL 265 ng•h/mL 160 L >99% Mostly CYP3A4 and CYP3A5. Lesser contributions from CYP1A2, CYP2C19, UGT1A1 2.5-6.1 hr Faeces (41%), urine (23%)
Axitinib
Ceritinib
Abrocitinib
Upadacitinib
Sunitinib
Afatinib
Erdafitinib
Dacomitinib